Brian Russell Wong M.D., Ph.D.
Net Worth
Last updated:
What is Brian Russell Wong M.D., Ph.D. net worth?
The estimated net worth of Dr. Brian Russell Wong M.D., Ph.D. is at least $8,525,200 as of 12 Oct 2020. He owns shares worth $3,599,160 as insider, has earned $801,040 from insider trading and has received compensation worth at least $4,125,000 in RAPT Therapeutics, Inc..
What is the salary of Brian Russell Wong M.D., Ph.D.?
Dr. Brian Russell Wong M.D., Ph.D. salary is $687,500 per year as Chief Executive Officer, Pres & Director in RAPT Therapeutics, Inc..
How old is Brian Russell Wong M.D., Ph.D.?
Dr. Brian Russell Wong M.D., Ph.D. is 53 years old, born in 1972.
What stocks does Brian Russell Wong M.D., Ph.D. currently own?
As insider, Dr. Brian Russell Wong M.D., Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| RAPT Therapeutics, Inc. (RAPT) | Chief Executive Officer, Pres & Director | 337,000 | $10.68 | $3,599,160 |
What does RAPT Therapeutics, Inc. do?
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Brian Russell Wong M.D., Ph.D. insider trading
RAPT Therapeutics, Inc.
Dr. Brian Russell Wong M.D., Ph.D. has made only one insider trade between 2019-2020, according to the Form 4 filled with the SEC. He sold 20,000 units of RAPT stock worth $801,040 on 12 Oct 2020.
As of 12 Oct 2020 he still owns at least 337,000 units of RAPT stock.
RAPT Therapeutics key executives
RAPT Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Brian Russell Wong M.D., Ph.D. (53) Chief Executive Officer, Pres & Director
- Dr. Dirk G. Brockstedt Ph.D. (56) Chief Scientific Officer
- Dr. William Ho (59) Chief Medical Officer